- Occlusion time affects behavior and lessions
- Intracerebral HD gene therapy delivery
- Guayusa-induced neurotransmitter release prefrontal cortex
- Osteoarthritic joint pain model in rat
- Screening HTT targets in hESC models
- In Vivo microdialysis quantification free brain cholesterol
- Holistic phenotyping strategy EAE MS Model
- Multiplexing inflammatory cytokines modeling neurodegenerative diseases
- In vitro characterization of TRAP antagonist
- Open science ALK2 inhibitors for DIPG
- High precision Qube assay = NaV1.X pharmacology
- HCI + ipSC = novel ALS targets
- New ELISA assay quantifies rodent HTT
- Early screening of 6-OHDA improves data
- HTS shift to genomic therapeutic modalities
- CNS therapy anesthesia risks for juveniles
- Functional neuroimaging pain and sensory disorders
- Comparing anxiety-like behaviors and neurochemistry in PD
- Validated iPCS neurons address model dilemma
- Multimodal and longitudinal characterization CLN Batten
- Novel translational creatine transporter deficient rat
- Htt-Q130-LEH novel heterozygous knock-in HD rat
- Use-dependent NMDAR modulation using the Qube
- Hot chilli capsaicin-induced pain model
- CMAP measurement for phenotyping and efficacy
- Characterizaton of humanized ASynA53TKI and aSynKO
- RTX rescued motor deficits in Parkinson's
- Gaucher models for PD studies
- Engineering antibody therapeutics for neurodegeneration
- Neurochemical changes in prenatal epilepsy model
- fUS for awake and behaving mice
- Visualization of pathologies in glioma longitudinally